Clinical Trials at Minnesota Oncology Hematology PA-Chaska
As of July 2026, 24 paid clinical trials are recruiting at Minnesota Oncology Hematology PA-Chaska, located at 110105 PIONEER TRL W, SUITE 302, CHASKA, MN 55318-2680, phone (952) 928-2900 in Chaska, Minnesota. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Metastatic Renal Cell Carcinoma and Anatomic Stage IV Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
24 clinical trials at Minnesota Oncology Hematology PA-Chaska
·Clear filters·↓ Download CSVFamily Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Mobile Health for Adherence in Breast Cancer Patients
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Common conditions studied in Chaska
- Malignant Solid Neoplasm (3 active studies)
- Metastatic Renal Cell Carcinoma (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- HER2-Negative Breast Carcinoma (2 active studies)
- Hormone Receptor-Positive Breast Carcinoma (2 active studies)
- Prostate Adenocarcinoma (2 active studies)
Leading research sponsors in Chaska
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
- National Cancer Institute (NCI)
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Chaska?
There are approximately 27 recruiting clinical trials in Chaska, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chaska pay participants?
Most recruiting trials in Chaska compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chaska?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chaska?
The most common conditions under active study in Chaska include Malignant Solid Neoplasm (3), Metastatic Renal Cell Carcinoma (3), Anatomic Stage IV Breast Cancer AJCC v8 (2), HER2-Negative Breast Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chaska?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chaska on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chaska?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chaska?
Recruiting research sites in Chaska include Minnesota Oncology Hematology PA-Chaska, Minnesota Oncology Hematology, P.A., Pain Centers of Minnesota, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chaska right now?
The largest active categories in Chaska are Cancer & tumors (22), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Minnesota Oncology Hematology PA-Chaska?
Minnesota Oncology Hematology PA-Chaska is located at 110105 PIONEER TRL W, SUITE 302, CHASKA, MN 55318-2680. Use the Google Maps link in the intro above to get directions.
How do I contact Minnesota Oncology Hematology PA-Chaska?
You can reach Minnesota Oncology Hematology PA-Chaska by phone at (952) 928-2900. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.